Pierre Hainaut

45.2k total citations · 7 hit papers
411 papers, 30.2k citations indexed

About

Pierre Hainaut is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Pierre Hainaut has authored 411 papers receiving a total of 30.2k indexed citations (citations by other indexed papers that have themselves been cited), including 203 papers in Oncology, 181 papers in Molecular Biology and 98 papers in Cancer Research. Recurrent topics in Pierre Hainaut's work include Cancer-related Molecular Pathways (167 papers), Cancer Genomics and Diagnostics (58 papers) and Epigenetics and DNA Methylation (56 papers). Pierre Hainaut is often cited by papers focused on Cancer-related Molecular Pathways (167 papers), Cancer Genomics and Diagnostics (58 papers) and Epigenetics and DNA Methylation (56 papers). Pierre Hainaut collaborates with scholars based in France, United States and United Kingdom. Pierre Hainaut's co-authors include Magali Olivier, Monica Hollstein, Amina Amadou, Amelie Plymoth, Lewis R. Roberts, Ju Dong Yang, Gregory J. Gores, Audrey Petitjean, J Milner and Gerd P. Pfeifer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

Pierre Hainaut

402 papers receiving 29.5k citations

Hit Papers

A global view of hepatoce... 1999 2026 2008 2017 2019 2009 2007 2002 2002 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A global view of hepatocellular carcinoma: trends, risk, prevention and management
    2019 2.9k citations Ju Dong Yang, Pierre Hainaut et al. Nature Reviews Gastroenterology & Hepatology profile →
  2. TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
    2009 1.5k citations Pierre Hainaut et al. profile →
  3. Impact of mutant p53 functional properties onTP53mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database
    2007 1.2k citations Pierre Hainaut et al. profile →
  4. The IARC TP53 database: New online mutation analysis and recommendations to users
    2002 980 citations Khan Ma, Curtis C. Harris et al. profile →
  5. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers
    2002 815 citations Stephen S. Hecht, Pierre Hainaut et al. profile →
  6. p53 and Human Cancer: The First Ten Thousand Mutations
    1999 788 citations Pierre Hainaut et al. profile →
  7. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes
    2007 689 citations Pierre Hainaut et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Hainaut France 84 15.9k 12.4k 8.3k 4.1k 3.2k 411 30.2k
Godefridus J. Peters Netherlands 92 18.0k 1.1× 16.5k 1.3× 5.6k 0.7× 5.4k 1.3× 2.1k 0.7× 854 35.0k
Ming‐Sound Tsao Canada 98 16.5k 1.0× 15.3k 1.2× 8.3k 1.0× 13.8k 3.4× 2.1k 0.7× 653 37.2k
Joannie Lortet‐Tieulent France 32 12.8k 0.8× 13.4k 1.1× 9.0k 1.1× 9.2k 2.3× 5.3k 1.7× 47 37.7k
Siwei Zhang China 56 10.9k 0.7× 9.9k 0.8× 7.7k 0.9× 7.0k 1.7× 2.8k 0.9× 235 28.3k
Daniel D. Von Hoff United States 91 19.7k 1.2× 23.6k 1.9× 8.3k 1.0× 6.7k 1.6× 4.1k 1.3× 821 44.9k
Paola Pisani Italy 43 10.4k 0.7× 11.8k 0.9× 5.9k 0.7× 6.7k 1.7× 6.2k 2.0× 131 34.5k
Manuel Hidalgo United States 85 12.5k 0.8× 18.5k 1.5× 7.4k 0.9× 7.0k 1.7× 2.2k 0.7× 448 29.7k
Rajesh Dikshit India 30 7.8k 0.5× 9.6k 0.8× 5.1k 0.6× 6.0k 1.5× 3.3k 1.1× 103 26.6k
Rongshou Zheng China 55 10.6k 0.7× 10.3k 0.8× 7.8k 0.9× 7.4k 1.8× 3.0k 0.9× 204 28.8k
Wanqing Chen China 62 11.2k 0.7× 10.8k 0.9× 8.1k 1.0× 7.9k 1.9× 3.1k 1.0× 301 31.1k

Countries citing papers authored by Pierre Hainaut

Since Specialization
Citations

This map shows the geographic impact of Pierre Hainaut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Hainaut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Hainaut more than expected).

Fields of papers citing papers by Pierre Hainaut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Hainaut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Hainaut. The network helps show where Pierre Hainaut may publish in the future.

Co-authorship network of co-authors of Pierre Hainaut

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Hainaut. A scholar is included among the top collaborators of Pierre Hainaut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Hainaut. Pierre Hainaut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Radu, A, Sandrine Blanchet, Emilie Montellier, et al.. (2025). Transcriptional regulation by LKB1 in lung adenocarcinomas: Exploring oxidative stress, neuroglial and amino acid signatures. Biochemical and Biophysical Research Communications. 755. 151571–151571.
2.
Levine, Arnold J., John D. Carpten, Maureen E. Murphy, & Pierre Hainaut. (2023). Exploring the genetic and molecular basis of differences in multiple myeloma of individuals of African and European descent. Cell Death and Differentiation. 31(1). 1–8. 3 indexed citations
3.
Stanfill, Stephen B., Stephen S. Hecht, Andreas C. Joerger, et al.. (2023). From cultivation to cancer: formation of N -nitrosamines and other carcinogens in smokeless tobacco and their mutagenic implications. Critical Reviews in Toxicology. 53(10). 658–701. 13 indexed citations
4.
Hausmann, Simone, Gaël S. Roth, Clément Oyeniran, et al.. (2022). SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation–Phosphorylation Cross-talk. Cancer Discovery. 12(9). 2158–2179. 18 indexed citations
5.
Yang, Ju Dong, Pierre Hainaut, Gregory J. Gores, et al.. (2019). A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nature Reviews Gastroenterology & Hepatology. 16(10). 589–604. 2931 indexed citations breakdown →
6.
7.
Gormally, Emmanuelle, Stéphanie Villar, Marlin D. Friesen, et al.. (2015). Molecular characteristics of Hepatitis B and chronic liver disease in a cohort of HB carriers from Bamako, Mali. BMC Infectious Diseases. 15(1). 180–180. 12 indexed citations
8.
Laffaire, Julien, Sylvie Lantuéjoul, Denis Moro‐Sibilot, et al.. (2014). Lung Squamous Cell Carcinomas with Basaloid Histology Represent a Specific Molecular Entity. Clinical Cancer Research. 20(22). 5777–5786. 32 indexed citations
9.
Douxfils, Jonathan, Fanny Buckinx, François Mullier, et al.. (2014). Dabigatran Etexilate and Risk of Myocardial Infarction, Other Cardiovascular Events, Major Bleeding, and All‐Cause Mortality: A Systematic Review and Meta‐analysis of Randomized Controlled Trials. Journal of the American Heart Association. 3(3). e000515–e000515. 77 indexed citations
10.
Bah, Ebrima, et al.. (2013). 20-Years of Population-Based Cancer Registration in Hepatitis B and Liver Cancer Prevention in The Gambia, West Africa. PLoS ONE. 8(9). e75775–e75775. 14 indexed citations
11.
Fraipont, Florence de, Guénaëlle Levallet, Christian Créveuil, et al.. (2012). An Apoptosis Methylation Prognostic Signature for Early Lung Cancer in the IFCT-0002 Trial. Clinical Cancer Research. 18(10). 2976–2986. 46 indexed citations
12.
Voortman, Johannes, Akiteru Goto, Jean Mendiboure, et al.. (2010). MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non–Small Cell Lung Carcinoma. Cancer Research. 70(21). 8288–8298. 109 indexed citations
13.
Vaught, Jimmie B., Élodie Caboux, & Pierre Hainaut. (2010). International Efforts to Develop Biospecimen Best Practices. Cancer Epidemiology Biomarkers & Prevention. 19(4). 912–915. 38 indexed citations
14.
Paliwal, Anupam, Thomas Vaissière, Annette M. Krais, et al.. (2010). Aberrant DNA Methylation Links Cancer Susceptibility Locus 15q25.1 to Apoptotic Regulation and Lung Cancer. Cancer Research. 70(7). 2779–2788. 53 indexed citations
15.
Clément-Duchêne, Christelle, Jean-Michel Vignaud, Odile Bertrand, et al.. (2009). Characteristics of never smoker lung cancer including environmental and occupational risk factors. Lung Cancer. 67(2). 144–150. 49 indexed citations
16.
Vaissière, Thomas, Rayjean J. Hung, Давид Заридзе, et al.. (2008). Quantitative Analysis of DNA Methylation Profiles in Lung Cancer Identifies Aberrant DNA Methylation of Specific Genes and Its Association with Gender and Cancer Risk Factors. Cancer Research. 69(1). 243–252. 207 indexed citations
17.
Burns, David, Erik Dybing, Nigel Gray, et al.. (2008). Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal. Tobacco Control. 17(2). 132–141. 199 indexed citations
18.
Mounawar, Mounia, Anush Mukeria, Florence Le Calvez‐Kelm, et al.. (2007). Patterns of EGFR, HER2, TP53 , and KRAS Mutations of p14arf Expression in Non–Small Cell Lung Cancers in Relation to Smoking History. Cancer Research. 67(12). 5667–5672. 83 indexed citations
19.
Calvez‐Kelm, Florence Le, Anush Mukeria, Jay D. Hunt, et al.. (2005). TP53 and KRAS Mutation Load and Types in Lung Cancers in Relation to Tobacco Smoke: Distinct Patterns in Never, Former, and Current Smokers. Cancer Research. 65(12). 5076–5083. 207 indexed citations
20.
Hernandez‐Boussard, Tina & Pierre Hainaut. (1998). A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database.. Environmental Health Perspectives. 106(7). 385–391. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Godefridus J. Peters Breakdown of academic impact, for papers by Ming‐Sound Tsao Breakdown of academic impact, for papers by Joannie Lortet‐Tieulent Breakdown of academic impact, for papers by Siwei Zhang Breakdown of academic impact, for papers by Daniel D. Von Hoff Breakdown of academic impact, for papers by Paola Pisani Breakdown of academic impact, for papers by Manuel Hidalgo Breakdown of academic impact, for papers by Rajesh Dikshit Breakdown of academic impact, for papers by Rongshou Zheng Breakdown of academic impact, for papers by Wanqing Chen
Rankless by CCL
2026